BioAdvance

BioAdvance is an evergreen life-sciences fund based in Conshohocken, Pennsylvania, investing in companies headquartered along the Mid-Atlantic I-95 corridor between New York City and Washington, D.C. (it also requires the CEO to be based in that region). It focuses on seed and Series A rounds, writing initial checks of $500,000 to $1.5 million and committing up to $5 million over a company's life,...